HKD 3.34
(-1.47%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -524.69 Million CNY | 48.78% |
2022 | -1.02 Billion CNY | 28.57% |
2021 | -1.43 Billion CNY | -125.71% |
2020 | -635.38 Million CNY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -51.75 Million CNY | 70.1% |
2024 Q2 | -51.75 Million CNY | 0.0% |
2023 Q2 | -89.24 Million CNY | 0.0% |
2023 FY | -524.69 Million CNY | 48.78% |
2023 Q3 | -173.1 Million CNY | -93.97% |
2023 Q1 | -89.24 Million CNY | 75.07% |
2023 Q4 | -173.1 Million CNY | 0.0% |
2022 FY | -1.02 Billion CNY | 28.57% |
2022 Q3 | -357.94 Million CNY | 0.0% |
2022 Q4 | -357.94 Million CNY | 0.0% |
2021 FY | -1.43 Billion CNY | -125.71% |
2020 FY | -635.38 Million CNY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 70.87 Million HKD | 840.303% |
CK Life Sciences Int'l., (Holdings) Inc. | 17.25 Million HKD | 3141.722% |